Financial report interval: 2025.07.01 - 2025.12.31
Preview: GENSCRIPT BIO(01548) predict that the Revenue is 3.429 B (+1233%), Miss estimate;the EBIT is 585.33 M (-53.68%), Miss estimate;the EPS is -1.82 (-116.3%), Miss estimate.